Glucagon testing in adult growth hormone deficiency - Current status and future perspectives

Kevin C J Yuen

Research output: Contribution to journalArticle

Abstract

Growth hormone deficiency (GHD) in adults is a recognised clinical syndrome and its diagnosis is established through GH stimulation testing. The decision to perform GH stimulation testing should be based on clinical findings, medical history and using the appropriate GH stimulation test to obtain biochemical evidence. The insulin tolerance test (ITT) remains the diagnostic test of choice, but this test is labour intensive, contraindicated in the elderly and in adults with seizure disorders and ischaemic heart disease, can be unpleasant for the patient, and is potentially hazardous. The glucagon stimulation test (GST) in recent years has been increasingly used as the alternative test to the ITT in the US and Europe because of its availability, reproducibility, safety, lack of influence by gender and hypothalamic cause of GHD, and relatively few contraindications. In the article, we discuss our recommendations in performing this test, the potential drawbacks in conducting and caveats in interpreting this test, and its future perspectives.

Original languageEnglish (US)
Pages (from-to)104-107
Number of pages4
JournalEuropean Endocrinology
Volume7
Issue number2
StatePublished - 2011

Fingerprint

Glucagon
Growth Hormone
Insulin
Routine Diagnostic Tests
Myocardial Ischemia
Epilepsy
Safety

Keywords

  • Adult growth hormone deficiency
  • Diagnosis
  • Glucagon
  • Growth hormone
  • Growth hormone releasing hormone plus arginine
  • Insulin tolerance test

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Endocrine and Autonomic Systems

Cite this

Glucagon testing in adult growth hormone deficiency - Current status and future perspectives. / Yuen, Kevin C J.

In: European Endocrinology, Vol. 7, No. 2, 2011, p. 104-107.

Research output: Contribution to journalArticle

@article{808b6c6ebc2747e3aa3450cab378c60e,
title = "Glucagon testing in adult growth hormone deficiency - Current status and future perspectives",
abstract = "Growth hormone deficiency (GHD) in adults is a recognised clinical syndrome and its diagnosis is established through GH stimulation testing. The decision to perform GH stimulation testing should be based on clinical findings, medical history and using the appropriate GH stimulation test to obtain biochemical evidence. The insulin tolerance test (ITT) remains the diagnostic test of choice, but this test is labour intensive, contraindicated in the elderly and in adults with seizure disorders and ischaemic heart disease, can be unpleasant for the patient, and is potentially hazardous. The glucagon stimulation test (GST) in recent years has been increasingly used as the alternative test to the ITT in the US and Europe because of its availability, reproducibility, safety, lack of influence by gender and hypothalamic cause of GHD, and relatively few contraindications. In the article, we discuss our recommendations in performing this test, the potential drawbacks in conducting and caveats in interpreting this test, and its future perspectives.",
keywords = "Adult growth hormone deficiency, Diagnosis, Glucagon, Growth hormone, Growth hormone releasing hormone plus arginine, Insulin tolerance test",
author = "Yuen, {Kevin C J}",
year = "2011",
language = "English (US)",
volume = "7",
pages = "104--107",
journal = "European Endocrinology",
issn = "1758-3772",
publisher = "Touch Briefings",
number = "2",

}

TY - JOUR

T1 - Glucagon testing in adult growth hormone deficiency - Current status and future perspectives

AU - Yuen, Kevin C J

PY - 2011

Y1 - 2011

N2 - Growth hormone deficiency (GHD) in adults is a recognised clinical syndrome and its diagnosis is established through GH stimulation testing. The decision to perform GH stimulation testing should be based on clinical findings, medical history and using the appropriate GH stimulation test to obtain biochemical evidence. The insulin tolerance test (ITT) remains the diagnostic test of choice, but this test is labour intensive, contraindicated in the elderly and in adults with seizure disorders and ischaemic heart disease, can be unpleasant for the patient, and is potentially hazardous. The glucagon stimulation test (GST) in recent years has been increasingly used as the alternative test to the ITT in the US and Europe because of its availability, reproducibility, safety, lack of influence by gender and hypothalamic cause of GHD, and relatively few contraindications. In the article, we discuss our recommendations in performing this test, the potential drawbacks in conducting and caveats in interpreting this test, and its future perspectives.

AB - Growth hormone deficiency (GHD) in adults is a recognised clinical syndrome and its diagnosis is established through GH stimulation testing. The decision to perform GH stimulation testing should be based on clinical findings, medical history and using the appropriate GH stimulation test to obtain biochemical evidence. The insulin tolerance test (ITT) remains the diagnostic test of choice, but this test is labour intensive, contraindicated in the elderly and in adults with seizure disorders and ischaemic heart disease, can be unpleasant for the patient, and is potentially hazardous. The glucagon stimulation test (GST) in recent years has been increasingly used as the alternative test to the ITT in the US and Europe because of its availability, reproducibility, safety, lack of influence by gender and hypothalamic cause of GHD, and relatively few contraindications. In the article, we discuss our recommendations in performing this test, the potential drawbacks in conducting and caveats in interpreting this test, and its future perspectives.

KW - Adult growth hormone deficiency

KW - Diagnosis

KW - Glucagon

KW - Growth hormone

KW - Growth hormone releasing hormone plus arginine

KW - Insulin tolerance test

UR - http://www.scopus.com/inward/record.url?scp=84860744524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860744524&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84860744524

VL - 7

SP - 104

EP - 107

JO - European Endocrinology

JF - European Endocrinology

SN - 1758-3772

IS - 2

ER -